Long-term enhancement of botulinum toxin injections by upper-eyelid surgery in 14 patients with facial dyskinesias

Archives of Otolaryngology - Head and Neck Surgery

Volumn 125, Issue 6, 1999, Pages 627-631

  Affliiricllo Jr , Joseph A ^a   Kcswani, Rohit ^a   Franklin, Mark ^a  

^a INSTITUTE OF OPHTHALMOLOGY AND VISUAL SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN;

ADULT; AGED; ARTICLE; BLEPHAROSPASM; CLINICAL ARTICLE; EYELID RECONSTRUCTION; FACE DISORDER; FEMALE; HEMIFACIAL SPASM; HUMAN; INJECTION; MALE; MEIGE DISEASE; MUSCLE RESECTION; OROFACIAL DYSKINESIA; RETROSPECTIVE STUDY; UPPER EYELID;

EID: 0033064368     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.125.6.627     Document Type: Article

References (21)

1. Gillum WN, Anderson RL. Blepharospasm surgery: an anatomical approach. Arch Ophthalmol. 1981:99:1056-1062.
2. McCord CD, Coles WH, Shore JW, et al. Treatment of essential blepharospasm, I: comparison of facial nerve avulsion and eyebrow-eyelid muscle stripping procedure. Arch Ophthalmol. 1984;102:266-268.
3. Frueh BR, Musch DC, BersaniTA. Effects of eyelid protractor excision for the treatment of benign essential blepharospasm. Am J Ophthalinol. 1992;113:681-686.
4. Garland PE, Patrinely JR, Anderson RL. Hemifacial spasm: results of unilateral myectomy. Ophthalmology. 1987;94:288-294.
5. Mauriello JA Jr, Dhillon S, Leone T, Pakeman B, Mostafavi R, Yepez MC. Treatment selections of 239 patients with blepharospasm and Meige syndrome over 11 years. Br J Ophthalmol. 1996:80:1073-1076.
6. Mauriello JA Jr, Leone T, Dhillon S, Pakeman B, Mostafavi R, Yepez MC. Treatment choices of 119 patients with hemifacial spasm over 11 years. Clin Neurol Neurosurg. 1996;98:213-216.
7. Jankovic J, Ford J. Blepharospasm and orofacial-cervical dystonia: clinical and pharmacologie findings in 100 patients. Ann Neurol. 1983:13:402-411.
8. Scott AN, Kennedy RA, Stubbs HA. Botulinum A toxin injections as a treatment for blepharospasm. Arch Ophthalmol. 1985:103:347-350.
9. Frueh BP, Musch DC. Treatment of facial spasm with botulinum toxin: an interim report. Ophthalmology. 1986:93:917-923.
10. Kraft SP, Long AE. Botulinum toxin injections in the treatment of blepharospasm, hemifacial spasm, and eyelid fasciculations. Can J Neurol Sci. 1988:15: 276-280.
11. Cohen DA, Savino PJ, Stem MB, et al. Botulinum injection therapy for blepharospasm: a review and report of 75 patients. Clin fJeuropharmacol. 1986;9:415-429.
12. Elston JS. Long-term results of treatment of idiopathic blepharospasm with botulinum toxin injections. Br J Ophthalmol. 1987:71:664-668.
13. Dutton JJ, Buckley EG. Long-term results and complications of Botulinum A toxin in the treatment of blepharospasm. Ophthalmology. 1988:95:1529-1534.
14. Borodic GE, Cozzolino G. Blepharospasm and its treatment, with emphasis on the use of botulinum toxin. Plast Reconstr Surg. 1989:83:546-554.
15. Mauriello JA Jr, Carbonaro P, Dhillon S, Leone T, Franklin M. Drug-associated facial dyskinesias: a study of 238 patients. Neuroophthalmology. 1998;18:153-157.
16. American Academy of Ophthalmology. Botulinum toxin therapy of eye muscle disorders: safety and effectiveness. Ophthalmology. 1989:51:767-772.
17. Marsden C. Blepharospasm-oromandibular dystonia syndrome (Brueghel's syndrome). J Neurol Neurosurg Psychiatry. 1976:39:1204-1209.
18. Jankovic J. Drug-induced and other orofacial-cervical dyskinesias. Ann Intern Med. 1981:94:788-793.
19. Mauriello JA Jr, Abdelsalam A. Modified levator aponeurotic advancement with delayed postoperative office revision. Ophlhal Plast Reconstr Surg. 1998:14: 266-270.
20. Frueh BR, Callahan A, Dortzbach RK, et al. The effects of differential section of the VIITH nerve on patients with intractable blepharospasm. Trans Am Acad Ophthalmol Otolaryngol. 1976:81 (pt 1):OP595-OP602.
21. Jordan DR, Anderson Rl, Digre KB. Apraxia of lid opening in blepharospasm. Ophthalmic Surg. 1990:21:331-334.